You have 9 free searches left this month | for more free features.

City

Shanghai (1)

Condition

Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd. (1)

Collaborator

Intervention

sim1803-1a (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

sim1803-1a

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion Trial in Shanghai (SIM1803-1A)

Recruiting

Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion

SIM1803-1A

Shanghai, China

Shanghai Chest Hospital

Jan 11, 2021